Department of Medical Physics
University of Wisconsin School of Medicine and Public Health

Paul M. DeLuca, Jr.

Credentials: Ph.D.

Position title: Board of Visitors Chair, Emeritus Professor, Emeritus Provost

Email: pmdeluca@wisc.edu

Phone: 608/261-1875

Address:
Department of Medical Physics, Wisconsin Institutes for Medical Research, 1111 Highland Avenue, Room 1005, Madison, WI 53705

Education

B.S., Physics, LeMoyne College, Syracuse, N.Y.

Ph.D., Nuclear Physics, Univ. of Notre Dame, Notre Dame, IN

Department Affilations

Medical Physics

Radiology

Human Oncology

Engineering Physics

Positions

  • 1985-Present, Professor, Dept. of Medical Physics, University of Wisconsin, Madison, WI
  • 1987-1998, Chairman, Dept. of Medical Physics, University of Wisconsin, Madison, WI
  • 1999-2009, Assoc. Dean, Research & Grad. Studies SMPH, University of Wisconsin, Madison, WI
  • 2001-2009, Vice Dean, Medical School, University of Wisconsin, Madison, WI
  • 2002-2005, Professor, Dept. of Engineering Physics, University of Wisconsin, Madison, WI
  • 2009-2014, Provost and Vice Chancellor for Academic Affairs, University of Wisconsin, Madison, WI

Research Interests

My current research focuses on the interaction of ionizing radiation with matter, specifically with implications to instrumentation and radiological physics measurements. Included in this work are the effects associated with fast neutrons in highly ionizing energetically charged particles useful for radiation therapy. Recent efforts have explored the applicability of very low energy photon radiation produced by energetic electrons. Examples include precise measurements of energy and proton power used in x-ray lithography, as well as imaging by photon induced electron emissions of live biological samples. Other interests include radiation protection (health physics), neutron dosimetry, radiobiological research with fast neutrons.

Awards and Honors

  • Fellow, American Association of Physicists in Medicine

Publications

  • Chadwick MB, DeLuca Jr. PM, and Haight RC, Nuclear Data Needs for Neutron Therapy and Radiation Protection, Rad. Prot. Dosim. 70(1-4)}, 1-12, 1997.
  • Newhauser WD, Schrewe UJ, Brede JH, Matzke M, and DeLuca Jr. PM, Kerma Measurements in Polyenergetic Neutron Fields, Rad. Prot. Dosim. 70(1-4)}, 13-16, 1997.
  • Ross MA, DeLuca Jr. PM, Jones DTL, Lennox A, and Maughan RL, Calculated Fluence Spectra at Neutron Therapy Facilities, Rad. Prot. Dosim. 70(1-4)}, 481-484, 1997.
  • Broerse JJ, DeLuca Jr. PM, Dietze G, Haight RC, and Hiraoka T, Nuclear Data for Neutron Therapy, Status and Future Needs, IAEA-TECDOC-992, International Atomic Energy Agency, Vienna, Austria, 1998.
  • MacKay JF, Pearson DW, Nelms BE, DeLuca Jr. PM, Gould MN and Lagally MG, A Double Mirror W/C Multilayer Monochromator for Radiation Biology Applications, Med. Phys. 25(5), 773-779, 1998.
  • Hill CK, Nelms BE, MacKay JF, Pearson D, Kennan WS, Mackie TR, DeLuca Jr PM, Lindstrom MJ, and Gould MN, Synchrotron-Produced Ultrasoft X rays: Equivalent Cell Survival at the Isoattenuating Energies 273 eV and 860 eV, Radiat. Res. 150, 513-520, 1998.
  • Nelms BE, Mackie TR, MacKay JF, Hill CK, DeLuca Jr PM, Lindstrom MJ, Deasy J, and Gould MN, A Comparison of Cytotoxicity Following Whole or Partial-Cell Irradiation with Synchrotron-Produced Ultrasoft X Rays, Radiat. Res. 150, 521-527, 1998.
  • Binns, P. J., P. M. DeLuca, et al. (1998). “Direct determination of kerma for a d(48.5)+Be therapy beam.” Physics in Medicine and Biology 43(12): 3449-3457.
  • Binns, P. J., P. M. DeLuca, et al. (1999). “Reply to ‘Comments on ‘Direct determination of kerma for a d(48.5)+Be therapy beam”.” Physics in Medicine and Biology 44(7): L14-L14.
  • Bohm, T. D., P. M. Deluca, et al. (1999). “Monte Carlo calculations to characterize the source for neutron therapy facilities.” Medical Physics 26(5): 783-792.
  • Wilson, G. J., G. E. Santyr, et al. (1999). “Longitudinal relaxation times of Xe-129 in rat tissue homogenates at 9.4 T.” Magnetic Resonance in Medicine 41(5): 933-938.
  • Chadwick, M. B., H. H. Barschall, et al. (1999). “A consistent set of neutron kerma coefficients from thermal to 150 MeV for biologically important materials.” Medical Physics 26(6): 974-991.
  • Chadwick, M. B., D. T. L. Jones, et al. (1999). “Nuclear data for radiotherapy: Presentation of a new ICRU report and IAEA initiatives.” Strahlentherapie Und Onkologie 175: 26-29.
  • Gould, M. N., B. E. Nelms, et al. (1999). “Radiobiological studies using synchrotron-produced ultrasoft X-rays.” Journal of Radiation Research 40: 66-73.
  • Schrewe, U. J., W. D. Newhauser, et al. (2000). “Experimental kerma coefficients and dose distributions of C, N, O, Mg, Al, Si, Fe, Zr, A-150 plastic, Al2O3, AlN, SiO2, and ZrO2 for neutron energies up to 66 MeV.” Physics in Medicine and Biology 45(3): 651-683.
  • Langen, K. M., P. J. Binns, et al. (2002). “Pileup correction of microdosimetric spectra.” Nuclear Instruments & Methods in Physics Research Section a-Accelerators Spectrometers Detectors and Associated Equipment 484(1-3): 595-612.
  • Langen, K. M., P. J. Binns, et al. (2003). “Measurement of the tissue to A-150 tissue equivalent plastic kerma ratio at two p(66)Be neutron therapy facilities.” Physics in Medicine and Biology 48(10): 1345-1359.
  • Bohm, T. D., P. M. DeLuca, et al. (2003). “Brachytherapy dosimetry of I-125 and Pd-103 sources using an updated cross section library for the MCNP Monte Carlo transport code.” Medical Physics 30(4): 701-711.
  • Miranda, J. G., P. M. DeLuca, et al. (2004). “Ion chamber gas-to-wall conversion factors for fast neutron dosimetry.” Radiation Protection Dosimetry 110(1-4): 15-25.
  • DeLuca, P. M., M. M. Goodsitt, et al. (2004). “Educational programs for imaging physicists should emphasize the science of imaging rather than the technology of imaging.” Medical Physics 31(10): 2727-2729.
  • Mistretta, C., P. DeLuca, et al. (2005). “John Roderick Cameron.” Physics Today 58(8): 69-70.
  • Bohm, T. D., S. L. Griffin, et al. (2005). “The effect of ambient pressure on well chamber response: Monte Carlo calculated results for the HDR 1000 plus.” Medical Physics 32(4): 1103-1114.
  • Avila-Rodriguez, M. A., P. M. DeLuca, et al. (2005). “Simulation of medical electron linac bremsstrahlung beam transport in typical shielding materials.” Radiation Protection Dosimetry 116(1-4): 547-552.
  • Mackie, T., M. Kissick, et al. (2006). “Simultaneous multi-pencil fan-beam-based intensity-modulated proton therapy.” Medical Physics33(6): 2296-2296.
  • Perez-Andujar, A., P. DeLuca, et al. (2007). “Neutron dose from thin, thick targets and passive proton beam delivery systems.” Medical Physics 34(6): 2633-2633.
  • DeLuca, P. M. (2008). “ICRU: a historical perspective of 90 years of radiation science.” Radiation Protection Dosimetry 132(4): 361-364.
  • Perez-Andujar, A., W. D. Newhauser, et al. (2009). “Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.” Physics in Medicine and Biology 54(4): 993-1008.
  • Sengbusch, E., A. Perez-Andujar, et al. (2009). “Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy.” Medical Physics 36(2): 364-372
  • Grudzinski, J.J., Yoriyaz, H, DeLuca, PM., Jr, Weichert, J,P. (2009) “Patient specific treatment planning for systemically administred radiopharmaceuticals using PET/CT and Monte Carlo simulation.” Applied Radiation and Isotopes 10:1016-1021.

Patents

5,668,371 Deasy,J, Mackie,TR, and DeLuca,PM, Method and apparatus for proton therapy, Madison, WI, September, 1997.

Memberships

  • American Association of Physicists in Medicine
  • American Physical Society
  • Health Physics Society
  • International Commission on Radiation Units and Measurements
  • National Council on Radiation Protection and Measurements